Literature DB >> 18557827

Red-blood-cell to plasma ratios transfused during massive transfusion are associated with mortality in severe multiple injury: a retrospective analysis from the Trauma Registry of the Deutsche Gesellschaft für Unfallchirurgie.

M Maegele1, R Lefering, T Paffrath, T Tjardes, C Simanski, B Bouillon.   

Abstract

BACKGROUND: To test whether an acute transfusion practice of packed red blood cells (pRBC) : fresh-frozen plasma (FFP) 1 : 1 would be associated with reduced mortality in acute bleeding multiply injury.
METHODS: Retrospective analysis using the TR-DGU database (Trauma Registry of the Deutsche Gesellschaft für Unfallchirurgie 2002-2006) on primary admissions with substantial injury (Injury Severity Score > 16) and massive transfusion (> 10 pRBCs). Seven hundred thirteen patients were divided into three groups according to the pRBC : FFP ratio transfused, that is, (i) pRBC : FFP > 1.1; (ii) pRBC : FFP 0.9-1.1 (1 : 1); and (iii) pRBC : FFP < 0.9, and mortality rates were compared.
RESULTS: Four hundred ninety-seven (69.7%) of patients were male, the mean age was 40.1 (+/- 18.3) years. Injury characteristics and pathophysiological state upon emergency room arrival were comparable between groups. Out of 713, 484 patients had undergone massive transfusion with pRBC : FFP > 1.1, 114 with pRBC : FFP 0.9-1.1 (1 : 1), and 115 with pRBC : FFP < 0.9 ratios. Acute mortality (< 6 h) rates for pRBC : FFP > 1.1, pRBC : FFP 0.9-1.1 (1 : 1), and pRBC : FFP < 0.9 ratios were 24.6, 9.6 and 3.5% (P < 0.0001), 24-h mortality rates were 32.6, 16.7 and 11.3% (P < 0.0001), and 30-day mortality rates were 45.5, 35.1 and 24.3% (P < 0.001). The frequency for septic complications and organ failure was higher in the pRBC : FFP 0.9-1.1 (1 : 1) group, ventilator days and length of stays for intensive care unit and overall in-hospital were highest in the pRBC : FFP < 0.9 ratio group (P < 0.0005).
CONCLUSIONS: An association between pRBC : FFP transfusion ratios and mortality to favour early aggressive FFP administration was observed. Further investigation is necessary prior to recommending routine 1 : 1 or more aggressive FFP use in exsanguinating patients.

Entities:  

Mesh:

Year:  2008        PMID: 18557827     DOI: 10.1111/j.1423-0410.2008.01074.x

Source DB:  PubMed          Journal:  Vox Sang        ISSN: 0042-9007            Impact factor:   2.144


  65 in total

1.  Creation, implementation, and maturation of a massive transfusion protocol for the exsanguinating trauma patient.

Authors:  Timothy C Nunez; Pampee P Young; John B Holcomb; Bryan A Cotton
Journal:  J Trauma       Date:  2010-06

2.  A multidisciplinary "think tank": the top 10 clinical trial opportunities in transfusion medicine from the National Heart, Lung, and Blood Institute-sponsored 2009 state-of-the-science symposium.

Authors:  Cassandra D Josephson; Simone A Glynn; Steve H Kleinman; Morris A Blajchman
Journal:  Transfusion       Date:  2010-10-04       Impact factor: 3.157

3.  Cryoprecipitate use in the PROMMTT study.

Authors:  John B Holcomb; Erin E Fox; Xuan Zhang; Nathan White; Charles E Wade; Bryan A Cotton; Deborah J del Junco; Eileen M Bulger; Mitchell J Cohen; Martin A Schreiber; John G Myers; Karen J Brasel; Herb A Phelan; Louis H Alarcon; Peter Muskat; Mohammad H Rahbar
Journal:  J Trauma Acute Care Surg       Date:  2013-07       Impact factor: 3.313

4.  Tips and tricks for the trauma patient.

Authors:  Anthony D Goei; Brian H Ching; Mark W Meyermann; Timothy Nunez; David Sacks
Journal:  Semin Intervent Radiol       Date:  2010-03       Impact factor: 1.513

Review 5.  Coagulopathy after severe pediatric trauma.

Authors:  Sarah C Christiaans; Amy L Duhachek-Stapelman; Robert T Russell; Steven J Lisco; Jeffrey D Kerby; Jean-François Pittet
Journal:  Shock       Date:  2014-06       Impact factor: 3.454

6.  Efficacy of a high FFP:PRBC transfusion ratio on the survival of severely injured patients: a retrospective study in a single tertiary emergency center in Japan.

Authors:  Daisuke Kudo; Junichi Sasaki; Satoshi Akaishi; Satoshi Yamanouchi; Tomoaki Koakutsu; Tomoyuki Endo; Takeaki Sato; Ryosuke Nomura; Hironao Yuzawa; Michio Kobayashi; Yotaro Shinozawa; Shigeki Kushimoto
Journal:  Surg Today       Date:  2013-02-19       Impact factor: 2.549

Review 7.  Transfusion management of trauma patients.

Authors:  Beth H Shaz; Christopher J Dente; Robert S Harris; Jana B MacLeod; Christopher D Hillyer
Journal:  Anesth Analg       Date:  2009-06       Impact factor: 5.108

8.  Goal-directed coagulation management of major trauma patients using thromboelastometry (ROTEM)-guided administration of fibrinogen concentrate and prothrombin complex concentrate.

Authors:  Herbert Schöchl; Ulrike Nienaber; Georg Hofer; Wolfgang Voelckel; Csilla Jambor; Gisela Scharbert; Sibylle Kozek-Langenecker; Cristina Solomon
Journal:  Crit Care       Date:  2010-04-07       Impact factor: 9.097

9.  Effect of Haemostatic Control Resuscitation on mortality in massively bleeding patients: a before and after study.

Authors:  P I Johansson; J Stensballe
Journal:  Vox Sang       Date:  2009-02       Impact factor: 2.144

Review 10.  Fibrinogen metabolic responses to trauma.

Authors:  Wenjun Zhou Martini
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2009-01-13       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.